Medical Grand Rounds - "Cancer Predisposition Genetics: Whom to Test?"
Presenter: Steven M. Lipkin, MD, PhD, Associate Professor of Genetic Medicine; Gladys and Roland Harriman Associate Professor of Medicine; Vice Chair for Research; Director, Genetics Clinic; Director, Program in Mendelian Genetics, Weill Cornell Medical College, Cornell University, New York, NY
At the conclusion of this activity, participants should be able to:
- Identify patients who meet criteria for hereditary breast and ovarian cancer genetic testing.
- Identify patients who meet criteria for hereditary colorectal cancer genetic testing.
- Identify patients who meet criteria for multiple primary cancer genetic testing.
- Compare/contrast germline cancer predisposition testing with somatic tumor therapy target testing.
Date, Time and Location: Friday, January 27, 2023 at noon on Microsoft Teams®
Register: Email Trish.Stern@guthrie.org to be included.
This program is intended for: Physicians, Advanced Practice Providers, Fellows, Residents, Medical and Nursing Students, and other Ancillary Healthcare Caregivers.
Accreditation Statement: “The Guthrie Clinic is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.”
Designation Statement: “The Guthrie Clinic designates this live activity for a maximum of (1.0) AMA PRA Category I Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”
Disclosure Statement: “Faculty and all others who have the ability to control the content of continuing medical education activities provided by The Guthrie Clinic are expected to disclose to the audience whether they do or do not have any real or apparent relevant financial relationships related to this educational activity.” “The presenting faculty/planning committee for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”